Raleigh drug firm lands FDA approval for treatment of intestinal infection affecting millions – WRAL Tech Wire

RALEIGH – RedHill Biopharma has received FDA approval for a treatment of a potentially deadly intestinal disease that affects 2 million people annually in the US and millions more worldwide.
The company announced early Monday the OK for its drug to treat H. …

Click here to view the original article.